| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to a pharmaceutical composition for local application containing a therapeutic compound of an immune response modifier, sterilisation-resistant and applicable for local application immediately on tissue regions with skin damages wherein said composition is sterilised by electron-beam irradiation, and the therapeutic compound represents 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinoline-4-amine (imiquimod). Also, the invention refers to a packed composition for local application containing a packing material and said pharmaceutical composition.EFFECT: invention provides the sterilisation-resistant pharmaceutical composition.26 cl, 5 tbl, 1 ex |
